(Q45400137)

English

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques (English)

1 reference

Europe PubMed Central

14 December 2017

1 reference

based on heuristic

inferred from title

author name string

Matthew B Elliott

1

1 reference

Europe PubMed Central

14 December 2017

Tong Chen

2

1 reference

Europe PubMed Central

14 December 2017

Nicole B Terio

3

1 reference

Europe PubMed Central

14 December 2017

Siew-Yen Chong

4

1 reference

Europe PubMed Central

14 December 2017

Rashed Abdullah

5

1 reference

Europe PubMed Central

14 December 2017

Amara Luckay

6

1 reference

Europe PubMed Central

14 December 2017

Michael A Egan

7

1 reference

Europe PubMed Central

14 December 2017

Lee Anne Boutilier

8

1 reference

Europe PubMed Central

14 December 2017

Krista Melville

9

1 reference

Europe PubMed Central

14 December 2017

Robert A Lerch

10

1 reference

Europe PubMed Central

14 December 2017

Deborah Long

11

1 reference

Europe PubMed Central

14 December 2017

John H Eldridge

12

1 reference

Europe PubMed Central

14 December 2017

Christopher L Parks

13

1 reference

Europe PubMed Central

14 December 2017

Stephen A Udem

14

1 reference

Europe PubMed Central

14 December 2017

Gerald E Hancock

15

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

21 August 2007

1 reference

Europe PubMed Central

14 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

25

1 reference

Europe PubMed Central

14 December 2017

41

1 reference

Europe PubMed Central

14 December 2017

7132-7144

1 reference

Europe PubMed Central

14 December 2017

Immunopathology of RSV infection: prospects for developing vaccines without this complication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

A review of vaccine research and development: human acute respiratory infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Prevention and treatment of respiratory syncytial virus infection in infants: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus infection in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus: reverse genetics and vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Carriers for the delivery of a vaccine against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus immunobiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Antigenic and genetic variation in human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Two distinct subtypes of human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

A novel viral system for generating antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus mRNA coding assignments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.07.065

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45400137&oldid=2076602263"